Suzhou Industrial Park Heshun Electric
300141
Guangdong Xiongsu Technology Group
300599
Sichuan Chuanhuan Technology
300547
Shanghai Wisdom Information Technology
301315
KANGNONG SEED
837403
CN Stock MarketDetailed Quotes
300529 Jafron Biomedical
- 30.21
- +0.48+1.61%
Market Closed Dec 27 15:00 CST
24.13BMarket Cap30.00P/E (TTM)
30.45High29.61Low46.93KlotVolume29.92Open29.73Pre Close141.63MTurnover0.92%Turnover Ratio55.23P/E (Static)798.61MShares39.2452wk High7.61P/B15.48BFloat Cap15.5052wk Low35.68Limit Up512.49MShs Float101.06Historical High23.78Limit Down2.83%Amplitude3.15Historical Low0.40Dividend TTM30.18Avg Price17.06KlotAsk1.32%Div YieldTTM100Lot Size28.57KlotBid
Jafron Biomedical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 47.76%2.2B | 47.77%1.5B | 30.00%744.34M | -22.84%1.92B | -26.64%1.49B | -34.88%1.01B | -17.90%572.56M | -6.88%2.49B | 13.69%2.03B | 30.80%1.55B |
| Operating revenue | 47.76%2.2B | 47.77%1.5B | 30.00%744.34M | -22.84%1.92B | -26.64%1.49B | -34.88%1.01B | -17.90%572.56M | -6.88%2.49B | 13.69%2.03B | 30.80%1.55B |
| Other operating revenue | ---- | 222.73%4.53M | ---- | -24.74%3.42M | ---- | 29.57%1.4M | ---- | 0.93%4.54M | ---- | -13.68%1.08M |
| Total operating cost | 26.44%1.28B | 22.05%861.39M | 20.39%421.94M | -8.35%1.42B | -4.87%1.01B | -3.00%705.76M | 11.51%350.49M | 16.29%1.55B | 29.75%1.07B | 46.81%727.58M |
| Operating cost | 42.80%410.33M | 47.87%291.11M | 41.52%158.66M | -12.75%383.98M | -15.14%287.35M | -21.85%196.86M | 3.74%112.11M | 9.46%440.11M | 26.28%338.6M | 43.93%251.89M |
| Operating tax surcharges | 49.75%35.05M | 52.64%23.97M | 37.04%11.67M | -9.28%31.82M | -17.71%23.41M | -29.58%15.71M | -22.55%8.51M | -12.41%35.07M | 6.97%28.45M | 26.51%22.3M |
| Operating expense | 15.69%510.26M | 5.31%340.76M | 1.00%158.5M | -12.08%615.97M | -4.46%441.05M | 6.31%323.58M | 26.13%156.94M | 17.07%700.63M | 26.14%461.66M | 38.80%304.37M |
| Administration expense | 14.25%128.71M | 16.13%84.67M | 39.32%38.47M | 28.40%177.39M | 22.60%112.65M | 16.30%72.91M | -5.14%27.61M | 5.48%138.15M | 13.88%91.88M | 34.02%62.69M |
| Financial expense | 185.67%23M | 145.20%8.1M | 105.47%476.36K | -90.21%-33.9M | -57.89%-26.85M | -32.70%-17.91M | -1,009.28%-8.71M | -43.27%-17.82M | -6.02%-17M | 5.41%-13.5M |
| -Interest expense (Financial expense) | 19.00%47.95M | 29.07%32.56M | 33.49%16.35M | 50.74%54.33M | 171.94%40.29M | 156.73%25.23M | 151.53%12.25M | 304.60%36.04M | 246.51%14.82M | 3,060.84%9.83M |
| -Interest Income (Financial expense) | 60.99%-26.13M | 43.46%-24.54M | 27.08%-15.65M | -65.15%-87.96M | -77.87%-67M | -62.99%-43.41M | -247.18%-21.46M | -91.63%-53.26M | -84.07%-37.67M | -70.16%-26.63M |
| Research and development | -0.93%174.72M | -1.60%112.79M | 0.27%54.17M | -3.36%245.38M | 8.67%176.36M | 14.82%114.62M | 32.50%54.02M | 46.12%253.91M | 68.86%162.28M | 95.09%99.82M |
| Credit Impairment Loss | -456.34%-8.73M | -299.36%-7.91M | -264.19%-1.28M | 320.33%8.23M | 130.26%2.45M | 151.83%3.97M | 115.65%777.07K | 130.33%1.96M | -4.30%-8.09M | -52.12%-7.66M |
| Asset Impairment Loss | ---15.32K | ---- | --0 | -332.78%-28.18M | ---- | --0 | --0 | -11,345.79%-6.51M | --0 | --0 |
| Other net revenue | 64.05%70.74M | 29.01%42.75M | 53.85%26.32M | -52.18%42.11M | -30.19%43.12M | -37.89%33.14M | 59.40%17.11M | 16.84%88.06M | 15.11%61.76M | 37.78%53.35M |
| Fair value change income | --334.75K | --5.8M | --1.01M | --0 | --0 | --0 | --0 | -200.00%-14.99K | ---14.99K | ---14.99K |
| Invest income | --24.69M | --8.18M | --2.53M | --0 | --0 | ---- | --0 | -63.34%10.52M | -39.61%10.48M | -22.32%9.66M |
| Asset deal income | -59.89%2.37M | -64.28%2.16M | -76.75%1.28M | 677.04%6.72M | 1,039.72%5.92M | 1,268.35%6.06M | 2,659.55%5.5M | -12.01%864.77K | -7.14%519.06K | 43.18%442.64K |
| Other revenue | 49.84%52.08M | 49.37%34.52M | 110.20%22.78M | -31.87%55.35M | -40.97%34.76M | -54.62%23.11M | 124.41%10.83M | 55.69%81.24M | 35.33%58.88M | 64.18%50.93M |
| Operating profit | 91.09%984.36M | 99.39%676.98M | 45.80%348.72M | -47.17%543.82M | -49.58%515.13M | -61.42%339.52M | -39.26%239.18M | -27.40%1.03B | 0.75%1.02B | 20.33%880.06M |
| Add:Non operating Income | -66.49%107.09K | -59.57%99.45K | -62.65%62.17K | -13.26%322.34K | 56.21%319.56K | 81.86%246.02K | 288.79%166.45K | -51.91%371.63K | -70.00%204.58K | -74.35%135.28K |
| Less:Non operating expense | 80.25%29.85M | 57.22%16.83M | 15.36%8.84M | 77.61%23.12M | 184.17%16.56M | 256.16%10.71M | 1,072.82%7.67M | 13.41%13.02M | -4.07%5.83M | 12.70%3.01M |
| Total profit | 91.35%954.62M | 100.65%660.25M | 46.73%339.93M | -48.76%521.02M | -50.90%498.89M | -62.49%329.06M | -41.07%231.68M | -27.74%1.02B | 0.73%1.02B | 20.29%877.19M |
| Less:Income tax cost | 111.33%165.79M | 103.29%109.5M | 53.74%56.01M | -29.86%95.3M | -46.58%78.45M | -58.94%53.86M | -38.01%36.43M | -35.72%135.86M | 0.24%146.87M | 19.06%131.18M |
| Net profit | 87.62%788.83M | 100.13%550.76M | 45.42%283.93M | -51.67%425.72M | -51.62%420.44M | -63.11%275.2M | -41.61%195.25M | -26.33%880.95M | 0.82%869.1M | 20.51%746.01M |
| Net profit from continuing operation | 87.62%788.83M | 100.13%550.76M | 45.42%283.93M | -51.67%425.72M | -51.62%420.44M | -63.11%275.2M | -41.61%195.25M | -26.33%880.95M | 0.82%869.1M | 20.51%746.01M |
| Less:Minority Profit | 12.79%-2.81M | 24.08%-1.75M | 34.49%-837.96K | -24.94%-10.77M | 25.96%-3.22M | -7.31%-2.31M | -56.54%-1.28M | -786.84%-8.62M | -325.93%-4.35M | -97.33%-2.15M |
| Net profit of parent company owners | 86.86%791.63M | 99.10%552.51M | 44.90%284.77M | -50.93%436.49M | -51.50%423.66M | -62.91%277.51M | -41.37%196.53M | -25.67%889.56M | 1.20%873.45M | 20.64%748.16M |
| Earning per share | ||||||||||
| Basic earning per share | 86.79%0.99 | 97.14%0.69 | 42.76%0.3512 | -50.89%0.55 | -51.82%0.53 | -62.37%0.35 | -41.43%0.246 | -24.83%1.12 | 1.85%1.1 | 19.23%0.93 |
| Diluted earning per share | 86.54%0.97 | 100.00%0.68 | 44.00%0.3495 | -49.56%0.57 | -51.85%0.52 | -63.44%0.34 | -40.80%0.2427 | -24.16%1.13 | 0.93%1.08 | 20.78%0.93 |
| Other composite income | 181.20%26.93M | -3,304.61%-33.17M | 1.81M | 1.81M | ||||||
| Other composite income of parent company owners | ---- | ---- | ---- | 181.20%26.93M | ---- | ---- | ---- | -3,304.61%-33.17M | --1.81M | --1.81M |
| Total composite income | 87.62%788.83M | 100.13%550.76M | 45.42%283.93M | -46.61%452.65M | -51.72%420.44M | -63.20%275.2M | -41.61%195.25M | -29.17%847.78M | 1.03%870.91M | 20.80%747.82M |
| Total composite income of parent company owners | 86.86%791.63M | 99.10%552.51M | 44.90%284.77M | -45.89%463.42M | -51.60%423.66M | -63.00%277.51M | -41.37%196.53M | -28.51%856.4M | 1.41%875.26M | 20.93%749.97M |
| Total composite income of minority owners | 12.79%-2.81M | 24.08%-1.75M | 34.49%-837.96K | -24.94%-10.77M | 25.96%-3.22M | -7.31%-2.31M | -56.54%-1.28M | -786.84%-8.62M | -325.93%-4.35M | -97.33%-2.15M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
